Summary
This scholarship opportunity is for a PhD candidate focusing on innovative therapies for genetic diseases, particularly utilizing antisense oligonucleotide strategies for treating rare metabolic disorders.
PhD Candidate – Developing Antisense Oligonucleotide Treatments for Metabolic Disease, Netherlands
Designation
PhD Candidate
Research Area
- Antisense Oligonucleotide Treatments
- Metabolic Diseases
- Genetic Disorders
- Molecular Life Sciences
Location
Radboud University Medical Center (Radboudumc), Nijmegen, Netherlands
Eligibility/Qualification
- MSc degree in Molecular Life Sciences or a related field
- Strong background in molecular and cell biology
- Hands-on experience with molecular techniques (PCR, cloning, RT-PCR, western blotting, cell culture, stem cell technology)
- Experience with molecular therapy (antisense technology) is a plus
- Self-motivated, collaborative with strong communication skills
Job Description
| Task | Role |
|---|---|
| Plan and perform scientific experiments independently | Lead experiments |
| Critically analyze data | Provide insightful data analysis |
| Report results | Document findings |
| Write manuscripts | Contribute to academic publications |
| Present data at scientific meetings | Actively engage in discussions |
| Supervise MSc and/or BSc students | Mentor junior researchers |
| Participate in group discussions | Collaborate with multidisciplinary teams |
How to Apply
Interested candidates should complete the application form on the official Radboudumc webpage, including CV and cover letter.
Last Date to Apply
April 17, 2026
This scholarship provides an excellent opportunity to work in a collaborative, interdisciplinary environment focused on impactful research in genetic therapies within the field of metabolic diseases.
